A Phase 4, Single-arm, Open-label Study to Evaluate the Effectiveness and Safety of Tezepelumab in Patients With Severe Asthma, Including Underrepresented Racial and Clinical Groups: Initial Baseline Demographics and Clinical Characteristics From the PASSAGE Study

被引：0
|
作者：
Lugogo, N. L. [1 ]
Sumino, K. [2 ]
Akuthota, P. [3 ]
Burnette, A. F. [4 ]
Mathur, S. K. [5 ]
Lindsley, A. W. [6 ]
Llanos, J. [7 ]
Marchese, C. [8 ]
Cook, B. [9 ]
Martin, N. [10 ]
Ambrose, C. S. [9 ]
Emmanuel, B. [9 ]
机构：
[1] Univ Michigan, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[2] Washington Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA
[3] Univ Calif San Diego, Div Pulm Crit Care & Sleep Med, La Jolla, CA 92093 USA
[4] Howard Univ, Div Allergy & Immunol, Washington, DC 20059 USA
[5] Univ Wisconsin, Dept Med, Div Allergy Pulm & Crit Care Med, Madison, WI USA
[6] Amgen Inc, US Med Affairs, Thousand Oaks, CA USA
[7] Amgen Inc, Global Med Affairs, Thousand Oaks, CA USA
[8] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Late Stage Dev, Gothenburg, Sweden
[9] AstraZeneca, BioPharmaceut Med, Resp & Immunol, Gaithersburg, MD USA
[10] AstraZeneca, BioPharmaceut Med, Resp & Immunol, Cambridge, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5374
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups
    Zimmer, L.
    Eigentler, T.
    Vaubel, J.
    Mohr, P.
    Jradi, Z.
    Kiecker, F.
    Utikal, J.
    Simon, J. -C.
    Berking, C.
    Kaempgen, E.
    Hauschild, A.
    Dippel, E.
    Rompel, R.
    Fluck, M.
    Stadler, R.
    Herbst, R. A.
    Terheyden, P.
    Loquai, C.
    Garbe, C.
    Schadendorf, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 32 - 32
  • [32] Safety and efficacy of hetrombopag in patients with chronic immune thrombocytopenia: a single-arm, open-label, multi-center phase 1 study
    Mei, Heng
    Chen, Xiequn
    Zhou, Jianfeng
    Luo, Jianmin
    Shi, Qingzhi
    Liu, Jing
    Wu, Depei
    Chen, Guoan
    Tai, Yanfei
    Xiong, Junye
    Zou, Jianjun
    Hu, Yu
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (02)
  • [33] Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study
    Namikawa, Kenjiro
    Kiyohara, Yoshio
    Takenouchi, Tatsuya
    Uhara, Hisashi
    Uchi, Hiroshi
    Yoshikawa, Shusuke
    Takatsuka, Sumiko
    Koga, Hiroshi
    Wada, Naoko
    Minami, Hironobu
    Hatsumichi, Masahiro
    Asada, Suguru
    Namba, Yoshinobu
    Yamazaki, Naoya
    EUROPEAN JOURNAL OF CANCER, 2018, 105 : 114 - 126
  • [34] Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study
    Srimuninnimit, Vichien
    Sriuranpong, Virote
    Suwanvecho, Suthida
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 255 - 260
  • [35] Efficacy and safety of DCVAC/LuCa with chemotherapy for patients with stage IV NSCLC: A prospective, open-label, single-arm, phase II study
    Ling, X.
    Xu, J.
    Zhong, R.
    Zhong, H.
    Han, B.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S752 - S753
  • [36] Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study)
    Leger, Jean-Marc
    De Bleecker, Jan L.
    Sommer, Claudia
    Robberecht, Wim
    Saarela, Mika
    Kamienowski, Jerzy
    Stelmasiak, Zbigniew
    Mielke, Orell
    Tackenberg, Bjoern
    Shebl, Amgad
    Bauhofer, Artur
    Zenker, Othmar
    Merkies, Ingemar S. J.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 (02) : 130 - 140
  • [37] A single-arm, open label, single center study to evaluate the safety and clinical outcome of using FR-Mask in breast cancer patients with radiation-irritated skin
    Chu, C-N.
    Wu, S-C.
    Bau, D-T.
    ANNALS OF ONCOLOGY, 2020, 31 : S87 - S87
  • [38] Possible Role of Platelet-Rich Plasma in the Treatment of Patients with Postherpetic Neuralgia: A Prospective, Single-Arm, Open-Label Clinical Study
    Abu El-Hamd, Mohammed
    Abd Elaa, Shereen G.
    Abdelwahab, Ashraf
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2024, 15 (06) : 986 - 991
  • [39] RESULTS FROM THE RATE-RA STUDY: A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE SAFETY OF ADMINISTERING RITUXIMAB AT A MORE RAPID INFUSION RATE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Pritchard, C. H.
    Greenwald, M. W.
    Kremer, J. M.
    Gaylis, N. B.
    Zlotnick, S.
    Chung, C.
    Jaber, B.
    Reiss, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 879 - 879
  • [40] Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
    Zimmer, Lisa
    Eigentler, Thomas K.
    Vaubel, Julia-Marianne
    Mohr, Peter
    Jradi, Zeinab
    Kiecker, Felix
    Utikal, Jochen
    Berking, Carola
    Kaempgen, Eckhart
    Hauschild, Axel
    Dippel, Edgar
    Rompel, Rainer
    Fluck, Michael
    Stadler, Rudolf
    Herbst, Rudolf
    Terheyden, Patrick
    Garbe, Claus
    Loquai, Carmen
    Schadendorf, Dirk
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345